Motta RGA, Morató LAE, Valenzuela TJ, Castillo GFA

Language: Spanish
References: 23
Page: 358-370
PDF size: 882.61 Kb.

ABSTRACT

Introduction: pancreatic focal neoplastic lesions (PFNL) should be characterized through image methods to differentiate from no neoplastic lesions, suggesting one or more probable diagnosis, and staging of malignant lesions, in order to help define the estrategy of medial or surgical management. The multidetector computed tomography (MDCT) offers multiple properties and advantages that enable adequate characterization of the PFNL. The objective of this study is to evaluate de usefulness of MDCT in characterizing PFNL. Material and methods: a descriptive, retrospective case series study has been conducted. It consisted of reviewing MDCT studies in which PFNL were found, over a period of 4 years 11 months from January 2006 to November 2010. Results: we obtained 54 cases of PFNL which were characterizedby MDCT; 75.9% for a specific diagnosis, and were categorized as indeterminate 24.1%, considering more than one possible diagnosis. The most frequent PFNL type was pancreatic ductal adenocarcinoma in 51.9%. Pancreatic cystic neoplasms accounted for 16.7%. Conclusions: MDCT is useful for identifying and characterizing LFNP, this means the possibility of establishing one or more diagnostic possibilities and guide medical management.

REFERENCES

1. Federle MP, Anne VS, Chen JJ, Guliani-Chabra S. Pancreas. In: Federle MP, Jeffrey RB, Desser TS, Anne VS, Eraso A. Diagnostic imaging: abdomen. 1.a ed. Manitoba, Canadá: Amirsys; 2005. p. II,3,2-63.

2. Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS. Focal or diffuse “fullness” of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. JOP. 2009;10:37-42.

3. Fernández-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003;138:427-33.

4. Sahani DV, Kadaviegere R, Saokar A, Fernández-del Castillo C, Brugge WR, Hahn PF. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics. 2005;25:1471-84.

5. Loyer EM, David CL, Dubrow RA, Evans DB, Charnsangavej C. Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. Abdom Imaging. 1996;21:202-6.

6. Lall CG, Howard TJ, Skandarajah A, Hewitt JM, Aisen AM, Sandrasegaran K. New concepts in staging and treatment of locally advanced pancreatic head cancer. AJR. 2007;189:1044-50.

7. Takeshita K, Kutomi K, Haruyaa T, et al. Imaging of early pancreatic cancer on multidetector row helical computed tomography. Br J Radiol. 2010;83:823-30.

8. Kalb B, Sarmiento JM, Kooby DA, Adsay NV, Martín DR. MR imaging of cystic lesions of the pancreas. Radiographics. 2009;29:1749-65.

9. Tanaka S, Nakao M, Loka T, Takakura R, Takano Y, Tsukuma H. Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer: a prospective study. Radiology. 2010;254:965-72.

10. Brugel M, Rummeny EJ, Dobritz M. Vascular invasion in pancreatic cancer: value of multislice helical CT. Abdom Imaging. 2004;29:239-45.

11. Kim JH, Park SH, Yu ES, et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257:87-96.

12. García-Figueiras R, Villalba Martín C, García-Figueiras A, et al. The spectrum of cystic masses of the pancreas: imaging features and diagnostic difficulties. Curr Probl Diagn Radiol. 2007;36:199-212.

13. Ferrone CR, Correa-Gallego C, Warshaw AL, et al. Current trends in pancreatic cystic neoplasms. Arch Surg. 2009;144:448-54.

14. Goh BK, Tan YM, Chung YF, et al. Non-neoplastic cystic and cystic-like lesions of the pancreas: may mimic pancreatic cystic neoplasms. ANZ J Surg. 2006;76:325-31.

15. Choi J, Kim M, Lee J, et al. Typical and atypical manifestations of serous cystadenoma of the pancreas: imaging findings with pathologic correlation. AJR. 2009;193:136-42.

16. Kim HJ, Lee DH, Ko YT, Lim JW, Kim HC, Kim KW. CT of serous cystadenoma of the pancreas and mimicking masses. AJR. 2008;190:406-12.

17. Sun HY, Kim SH, Kim MA, Lee JY, Han JK, Choi BI. CT imaging spectrum of pancreatic serous tumors: based on new pathologic classification. EJR. 2010;75:65-75.

18. Irie H, Yoshimitsu K, Tajima T, et al. Imaging spectrum of cystic pancreatic lesions: learn from atypical cases. Curr Probl Diagn Radiol. 2007;36:213-26.

19. Kim SY, Le JM, Kim SH, et al. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. AJR. 2006;187:1192-8.

20. Matthew NT, Paul RD, Yang CK. Pancreatic imaging current and emerging technologies. Pancreas. 2006;33:211-20.

21. Choi JY, Kim MJ, Kim JH, et al. Solid pseudopapillary tumor of the pancreas: typical and atypical manifestations. AJR. 2006;187:178-86.

22. Hague J, Amin Z. Focal pancreatic lesion: can a neoplasm be confidently excluded? Br J Radiol. 2006;79:627-9.

23. Kawamoto S, Horton KM, Lawler LP, Urban RH, Fishman EK. Intraductal papillary mucinous neoplasm of the pancreas: can benign lesions be differentiated from malignant lesions with multidetector CT? Radiographics. 2005;25:1451-68.